Plain-English translation of NCT03059043 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new way to perform Implantable Collamer Lens (ICL) surgery for people with severe nearsightedness. The new method skips a step that the standard surgery uses, potentially making the procedure faster and reducing pressure spikes in the eye after surgery. You would have one eye treated with the new method and the other eye treated with the standard method, so doctors can directly compare how well both work.
The standard ICL surgery uses a gel-like substance to protect the eye during implantation, but this gel must be carefully removed afterward and sometimes causes uncomfortable pressure buildup in the eye. The new treatment uses a simpler salt solution instead, which may eliminate these problems while working just as well.
You likely qualify if…
You likely don't qualify if…
You would receive ICL surgery on both eyes during the same procedure—one eye using the new simplified method and the other using the standard method. After surgery, you would return for follow-up visits at 2 hours, 1 day, 1 week, 1 month, 3 months, and 6 months to have your vision checked and your eye health monitored. The visits measure how well each method works and whether either causes any side effects like pressure spikes.
AI-generated summary from trial data · Oct 12, 2026 · Not medical advice
China